Ayurveda and Alzheimer's: What Research Shows on Brahmi and Ashwagandha
Brahmi (Bacopa monnieri) and ashwagandha interest researchers studying memory and cognition. Here's what the studies actually show, and why they don't concern Alzheimer's disease itself.
Alzheimer's disease is a serious neurodegenerative condition that falls exclusively under the diagnosis and follow-up of a doctor or neurologist. No herb, including in Ayurveda, treats, cures or has been shown to slow this disease. This article reviews, with all the caution the topic demands, what research has explored around brahmi (Bacopa monnieri) and ashwagandha regarding memory and cognition — a very different subject from diagnosed Alzheimer's disease. It completes our series of guides on chronic diseases, echoing our article on Ayurveda and Parkinson's.
Ayurveda and Alzheimer's: an essential distinction to state upfront
In traditional Ayurveda, brahmi is classified among the medhya rasayana, substances traditionally associated with supporting intellect and memory. This classification is ancient and belongs to a traditional system of thought, not clinical proof of treating a neurodegenerative disease. Modern scientific research on brahmi and brahmi/">ashwagandha overwhelmingly concerns healthy adults or those with mild cognitive impairment (MCI) — never patients with an established diagnosis of Alzheimer's disease. Conflating these two situations would be a potentially dangerous mistake, since it could delay necessary medical care.
What a clinical study shows about brahmi and memory
A study by Calabrese, Gregory, Leo, Kraemer, Bone and Oken, published in 2008 in the Journal of Alternative and Complementary Medicine, ran a randomized, double-blind, placebo-controlled trial in 54 people aged 65 and older, with no clinical sign of dementia, receiving 300mg per day of standardized Bacopa monnieri extract for twelve weeks, after a preliminary six-week placebo phase for the whole cohort (see the study on Google Scholar). The results show a mild improvement in delayed recall scores on the auditory verbal learning test (AVLT) in the brahmi group compared with placebo, along with reduced anxiety and depression scores. No significant effect was observed, however, on other cognitive tests (divided attention, working memory).
This work involved a modest sample of 54 older participants with no diagnosed dementia, over only twelve weeks, with effects measured as mild. It says nothing about the effect of brahmi in people with Alzheimer's disease, whose pathophysiology (amyloid plaque accumulation, neurofibrillary degeneration) is far more complex than a simple age-related memory deficit.
What about ashwagandha?
Ashwagandha (Withania somnifera) is also the subject of preliminary work on mild cognitive decline, with trials exploring effects on attention and immediate memory in small groups of participants with MCI. This data, too, remains at a limited level of evidence (small samples, short durations) and does not concern established Alzheimer's disease. As with brahmi, these are research leads on cognition in general, not validated treatments for a neurodegenerative disease.
Other herbs traditionally classified among the medhya rasayana, such as gotu kola, draw similar interest in the Ayurvedic literature, but with an even more limited level of clinical research in humans regarding memory. The takeaway is the same for all these herbs: genuine research interest in general cognition, no proof of efficacy against a diagnosed neurodegenerative disease.
What this does not mean
| Common belief | Reality |
|---|---|
| "Brahmi treats Alzheimer's disease" | False: no study has been conducted in patients with an established Alzheimer's diagnosis |
| "An improvement in memory in healthy seniors proves an effect on dementia" | False: age-related cognitive decline and Alzheimer's disease are two distinct pathophysiological realities |
| "Ayurvedic herbs can replace neurological follow-up" | Dangerous: any concerning memory trouble must be evaluated by a doctor, not managed alone with herbs |
| "It's natural, so it's safe to combine with a treatment" | Must be validated with the care team, especially alongside an ongoing treatment (possible interactions) |
What you should never do
- Never delay a medical or neurological consultation for a concerning memory trouble, disorientation, or suspected dementia, in favor of self-medicating with herbs.
- Never present brahmi or ashwagandha as a treatment for Alzheimer's disease: no study demonstrates this, and no slowing of the disease has been established.
- Never substitute these herbs for a treatment or care prescribed by the care team of an already-diagnosed patient.
- Never combine these herbs with an ongoing treatment (cholinesterase inhibitors, anticoagulants, sedatives, thyroid treatments particularly with ashwagandha) without first talking to the doctor, due to possible interactions.
Precautions
A concerning memory trouble, whether repeated forgetfulness, disorientation in time or space, or behavioral changes, should always be evaluated by a treating physician or neurologist: only a medical diagnosis can distinguish normal cognitive aging, mild cognitive impairment, and Alzheimer's disease or another dementia. Brahmi and ashwagandha never replace this diagnosis or the care that follows from it. Any use of these herbs should be reported to the care team, especially alongside an ongoing medication. To learn more about everyday memory, see our articles on focus and memory and brain fog, as well as our safety guide.
Your questions about ayurveda and alzheimer's
Can brahmi treat or slow Alzheimer's disease?
No, no clinical study demonstrates this. Available research on brahmi concerns the memory of older people without dementia or with mild cognitive impairment, never patients diagnosed with Alzheimer's.
What study exists on brahmi and seniors' memory?
A study by Calabrese et al., published in 2008 in the Journal of Alternative and Complementary Medicine, showed a mild improvement in delayed recall after twelve weeks of Bacopa monnieri extract, compared with placebo, in 54 people aged 65 and older with no dementia.
Does ashwagandha have a demonstrated effect on mild cognitive decline?
Preliminary trials explore this lead in small groups of participants with mild cognitive impairment (MCI), with encouraging but still limited-quality evidence. This does not concern established Alzheimer's disease.
Can brahmi or ashwagandha be combined with an Alzheimer's treatment?
Only after the advice of the doctor or neurologist following the patient, due to possible interactions with certain treatments, notably cholinesterase inhibitors.
When should you see a doctor for a memory trouble?
As soon as repeated forgetfulness, disorientation or behavioral changes become concerning, you should see a doctor promptly: only a medical diagnosis can distinguish normal aging from a neurodegenerative disease like Alzheimer's.
Free guide
Your 7-step Ayurvedic morning routine
The condensed dinacharya: seven realistic steps with timings, the 15-minute weekday version and dosha adjustments. Enter your email and read it right away — no PDF to hunt for, no spam.